These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24285063)

  • 21. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
    Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M
    Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021
    [No Abstract]   [Full Text] [Related]  

  • 22. Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis - was Demodex the culprit?
    Lotze C; Krüger WH; Kiefer T; Swensson O; Herbst EW; Schüler F; Busemann C; Dölken G
    Bone Marrow Transplant; 2006 Apr; 37(7):711-2. PubMed ID: 16474408
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidermodysplasia verruciformis in the setting of graft-versus-host disease.
    Kunishige JH; Hymes SR; Madkan V; Wyatt AJ; Uptmore D; Lazar AJ; Giralt S; Rady P; Tyring S
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S78-80. PubMed ID: 17938030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia.
    Ozdemir E; Molldrem JJ
    Bone Marrow Transplant; 2006 Apr; 37(8):785-6. PubMed ID: 16501592
    [No Abstract]   [Full Text] [Related]  

  • 25. Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation.
    Sorà F; Chiusolo P; Metafuni E; Bellesi S; Giammarco S; Laurenti L; Ausoni G; Zini G; Bayer AJ; Mario B; Leone G; Sica S
    Leuk Res; 2011 Mar; 35(3):422-3. PubMed ID: 21093053
    [No Abstract]   [Full Text] [Related]  

  • 26. [Graft vs host disease].
    Moalic V; Ferec C
    Pathol Biol (Paris); 2006 May; 54(5):304-8. PubMed ID: 16530350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe intestinal graft-versus-host disease following autologous stem cell transplantation.
    Kline J; van Besien K; Nathanson J; Noffsinger A; Artz A
    Bone Marrow Transplant; 2006 Sep; 38(5):391-2. PubMed ID: 16915228
    [No Abstract]   [Full Text] [Related]  

  • 28. Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation.
    Mousset S; Bug G; Heinz WJ; Tintelnot K; Rickerts V
    Transpl Infect Dis; 2010 Jun; 12(3):261-4. PubMed ID: 19954497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lichen sclerosus et atrophicus-like chronic graft-versus-host disease.
    Saxena A; Kasper DA; Webster C; Lee JB
    Eur J Dermatol; 2006; 16(6):700-1. PubMed ID: 17229623
    [No Abstract]   [Full Text] [Related]  

  • 30. Esophageal graft versus host disease.
    Sodhi SS; Srinivasan R; Thomas RM
    Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
    [No Abstract]   [Full Text] [Related]  

  • 31. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.
    Ruiz-Argüelles GJ; Gómez-Almaguer D; López-Martínez B; Cantú-Rodríguez OG; Jaime-Pérez JC; González-Llano O
    Haematologica; 2002 Aug; 87(8):894-6. PubMed ID: 12161373
    [No Abstract]   [Full Text] [Related]  

  • 32. Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease.
    Piñana JL; Valcárcel D; Martino R; Moreno ME; Sureda A; Briones J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1135-41. PubMed ID: 17085306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of graft-versus-host disease in the inhibition of normal B-lymphopoiesis and leukemic control of B-lineage acute lymphocytic leukemia after allogeneic stem cell transplantation.
    Handgretinger R
    Haematologica; 2006 Mar; 91(3):292B. PubMed ID: 16531250
    [No Abstract]   [Full Text] [Related]  

  • 35. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation.
    Schulenburg A; Turetschek K; Wrba F; Vogelsang H; Greinix HT; Keil F; Mitterbauer M; Kalhs P
    Ann Hematol; 2004 Feb; 83(2):101-6. PubMed ID: 14615909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful use of Campath-1H in the treatment of steroid refractory liver GvHD.
    Wandroo F; Auguston B; Cook M; Craddock C; Mahendra P
    Bone Marrow Transplant; 2004 Aug; 34(3):285-7. PubMed ID: 15170160
    [No Abstract]   [Full Text] [Related]  

  • 37. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion.
    Gesundheit B; Shapira MY; Maly A; Samuel S; Budowski E; Or R
    Leuk Res; 2008 Mar; 32(3):501-3. PubMed ID: 17727947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
    Ziemer M; Thiele JJ; Gruhn B; Elsner P
    J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
    [No Abstract]   [Full Text] [Related]  

  • 40. Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease.
    Bonanomi S; Balduzzi A; Tagliabue A; Biagi E; Rovelli A; Corti P; Crippa D; Uderzo C
    Bone Marrow Transplant; 2001 Sep; 28(6):631-2. PubMed ID: 11607781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.